• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.16% Nasdaq Up0.25%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    11.53 Down 0.27(2.29%) Jun 1, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 14,842   33,905   28,002   27,815  
    Cost of Revenue -   -   -   -  
    Gross Profit 14,842   33,905   28,002   27,815  
    Operating Expenses
    Research Development35,679  30,744  43,632  33,795  
    Selling General and Administrative9,189  8,277  8,095  7,921  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (30,026) (5,116) (23,725) (13,901)
    Income from Continuing Operations
    Total Other Income/Expenses Net160  203  272  181  
    Earnings Before Interest And Taxes(29,866)(4,913)(23,453)(13,720)
    Interest Expense4,566  4,564  4,585  4,570  
    Income Before Tax(34,432)(9,477)(28,038)(18,290)
    Income Tax Expense -   -   -   -  
    Minority Interest(327)(219)137  181  
    Net Income From Continuing Ops(34,759)(9,696)(27,901)(18,109)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (34,759) (9,696) (27,901) (18,109)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (34,759) (9,696) (27,901) (18,109)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.